Piramal Pharma Ltd (PPLPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003728, "name": "Piramal Pharma", "stock_name": "Piramal Pharma", "full_name": "Piramal Pharma Ltd", "name_url": "stocks-analysis/piramal-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "209.40", "chg": 1.1, "chgp": "0.53%", "dir": 1, "prev_price": "208.30", "mcapval": "27,792.00 Cr", "mcap": "Small Cap", "scripcode": 543635, "symbol": "PPLPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE0DK501011", "curr_date": "Aug 07, 03:30 PM", "curr_time": "20:03 PM", "last_traded_at": "Aug 07, 03:30 PM IST", "bse_nse_vol": "50.67 lacs", "exc_status": "Active", "traded_date": "Aug 07, 2026", "traded_date_str": "2026 08 07", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/piramal-pharma-1003728-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Piramal Pharma Gains 6.78%: 3 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-gains-678-3-key-factors-driving-the-weeks-momentum-4143031", "imagepath": "", "date": "2026-08-08 11:05:41", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> Stock opens week at ₹199.00, up 1.48%</p>\n <p><strong>4 Aug:</strong> Technical momentum shifts amid mixed indicator signals</p>\n <p><strong>5 Aug:</strong> Bullish momentum confirmed with 1.71% gain</p>\n <p><strong>6 Aug:</strong> New 52-week high at ₹212.45</p>\n <p><strong>7 Aug:</strong> Week closes at ₹209.40, up 6.78% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.196.10</div></div>\n <div class=\"stat-item\"><div class=\"stat-lab..." }, { "title": "Piramal Pharma Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-ltd-is-rated-sell-by-marketsmojo-4142908", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/PiramalPharmaLt_mojoScore_4142908.png", "date": "2026-08-08 10:10:16", "description": "Piramal Pharma Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 August 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Piramal Pharma Ltd Hits New 52-Week High of Rs 212.45 on Back of Strong Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-hits-new-52-week-high-at-rs21245-4140001", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/PiramalPharmaLt_priceRelatedfactors_4140001.png", "date": "2026-08-06 10:23:28", "description": "From a 52-week low of Rs 132.50 to a fresh high of Rs 212.45, Piramal Pharma Ltd has delivered an 11.5% return over the past year, comfortably outpacing the Sensex’s decline of 2.3%. This milestone caps a four-day winning streak that has propelled the stock above all major moving averages, signalling robust price momentum." }, { "title": "Piramal Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-mixed-indicators-4137159", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/PiramalPharmaLt_technicaldot_4137159.png", "date": "2026-08-05 08:07:21", "description": "Piramal Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a mixed bag of monthly and weekly technical indicators, the stock’s recent price action and moving averages suggest an improving outlook for this small-cap pharmaceutical player, even as its MarketsMOJO Mojo Grade was downgraded to Sell from Hold on 16 Jul 2026." }, { "title": "Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4135415", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/PiramalPharmaLt_technicaldot_4135415.png", "date": "2026-08-04 08:10:36", "description": "Piramal Pharma Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early August 2026. Despite a recent upgrade in daily moving averages and weekly MACD signals, monthly indicators present a more cautious outlook, reflecting a complex interplay of bullish and bearish forces in the Pharmaceuticals & Biotechnology sector." }, { "title": "Piramal Pharma Gains 8.25%: 6 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-gains-825-6-key-factors-driving-the-weeks-momentum-4131358", "imagepath": "", "date": "2026-08-01 11:03:39", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> Stock surges 6.02% on technical momentum shift</p>\n <p><strong>28 Jul:</strong> Technical indicators signal bullish outlook</p>\n <p><strong>30 Jul:</strong> Exceptional volume surge amid sustained gains</p>\n <p><strong>30 Jul:</strong> Q1 FY27 results reveal margin pressures and losses</p>\n <p><strong>31 Jul:</strong> Quality grade downgraded highlighting fundamental challenges</p>\n <p><strong>31 Jul:</strong> Valuation shifts prompt mojo grade downgrade to Sell</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"..." }, { "title": "Piramal Pharma Ltd Valuation Shifts Signal Price Attractiveness Concerns", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-valuation-shifts-signal-price-attractiveness-concerns-4129488", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/PiramalPharmaLt_valuationdot_4129488.png", "date": "2026-07-31 08:01:10", "description": "Piramal Pharma Ltd has experienced a notable shift in its valuation parameters, moving from a fair to an expensive rating, prompting a downgrade in its Mojo Grade from Hold to Sell. Despite recent positive price momentum, the company’s elevated price-to-earnings and price-to-book ratios relative to historical and peer averages raise questions about its current price attractiveness for investors." }, { "title": "Piramal Pharma Ltd Quality Grade Downgrade Highlights Fundamental Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-quality-grade-downgrade-highlights-fundamental-challenges-4129348", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/PiramalPharmaLt_qualitydot_4129348.png", "date": "2026-07-31 08:00:07", "description": "Piramal Pharma Ltd has recently experienced a downgrade in its quality grade from 'Average' to 'Below Average' as of 16 July 2026, reflecting a notable deterioration in key business fundamentals. This shift accompanies a downgrade in the Mojo Grade from Hold to Sell, signalling growing concerns over the company’s operational efficiency, profitability, and capital structure amid a challenging pharmaceutical sector landscape." }, { "title": "Are Piramal Pharma Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-piramal-pharma-ltd-latest-results-good-or-bad-4129093", "imagepath": "", "date": "2026-07-30 19:23:11", "description": "Piramal Pharma Ltd's latest financial results for Q1 FY27 present a mixed operational picture. The company reported consolidated net sales of ₹2,269.92 crores, reflecting a year-on-year growth of 17.39%. This increase was driven by improved demand in its Contract Development and Manufacturing Organisation (CDMO) and Consumer Healthcare segments. However, there was a significant sequential decline of 17.51% compared to the previous quarter, indicating volatility in pharmaceutical order flows.\n\nDespite the revenue growth, Piramal Pharma faced challenges with profitability, as evidenced by a consolidated net loss of ₹69.39 crores, which widened substantially compared to the previous quarter. The operating margin, while showing a year-on-year improvement to 8.60%, was considerably lower than the 16.74% margin achieved in the previous quarter. This highlights ongoing operational inefficiencies and high financial..." } ], "total": 482, "sid": "1003728", "stock_news_url": "https://www.marketsmojo.com/news/piramal-pharma-1003728" }, "announcements": [ { "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -Resumption Of Operations At CompanyS Facilities Located At Ahmedabad Gujarat", "datetime": "03-Aug-2026", "details": "Please refer attachment", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "31-Jul-2026", "details": "Please find enclosed details of Earning call Transcript held on 30th July 2026.", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM", "datetime": "30-Jul-2026", "details": "Proceedings and Voting Results of the 6th Annual General Meeting of the Company", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Piramal Pharma Ltd has declared <strong>1%</strong> dividend, ex-date: 16 Jul 25", "dt": "2025-07-16", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Piramal Pharma Ltd has announced <strong>5:46</strong> rights issue, ex-date: 02 Aug 23", "dt": "2023-08-02", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

3 Aug: Stock opens week at ₹199.00, up 1.48%

4 Aug: Technical momentum shifts amid mixed indicator signals

5 Aug: Bullish momentum confirmed with 1.71% gain

6 Aug: New 52-week high at ₹212.45

7 Aug: Week closes at ₹209.40, up 6.78% for the week

Week Open

Rs.196.10

Read full news article

Piramal Pharma Ltd is Rated Sell by MarketsMOJO

2026-08-08 10:10:16

Piramal Pharma Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Piramal Pharma Ltd Hits New 52-Week High of Rs 212.45 on Back of Strong Technical Signals

2026-08-06 10:23:28

From a 52-week low of Rs 132.50 to a fresh high of Rs 212.45, Piramal Pharma Ltd has delivered an 11.5% return over the past year, comfortably outpacing the Sensex’s decline of 2.3%. This milestone caps a four-day winning streak that has propelled the stock above all major moving averages, signalling robust price momentum.

Read full news article

Piramal Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators

2026-08-05 08:07:21

Piramal Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a mixed bag of monthly and weekly technical indicators, the stock’s recent price action and moving averages suggest an improving outlook for this small-cap pharmaceutical player, even as its MarketsMOJO Mojo Grade was downgraded to Sell from Hold on 16 Jul 2026.

Read full news article

Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-08-04 08:10:36

Piramal Pharma Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early August 2026. Despite a recent upgrade in daily moving averages and weekly MACD signals, monthly indicators present a more cautious outlook, reflecting a complex interplay of bullish and bearish forces in the Pharmaceuticals & Biotechnology sector.

Read full news article

Piramal Pharma Gains 8.25%: 6 Key Factors Driving the Week’s Momentum

2026-08-01 11:03:39

Key Events This Week

27 Jul: Stock surges 6.02% on technical momentum shift

28 Jul: Technical indicators signal bullish outlook

30 Jul: Exceptional volume surge amid sustained gains

30 Jul: Q1 FY27 results reveal margin pressures and losses

31 Jul: Quality grade downgraded highlighting fundamental challenges

31 Jul: Valuation shifts prompt mojo grade downgrade to Sell

Read full news article

Piramal Pharma Ltd Valuation Shifts Signal Price Attractiveness Concerns

2026-07-31 08:01:10

Piramal Pharma Ltd has experienced a notable shift in its valuation parameters, moving from a fair to an expensive rating, prompting a downgrade in its Mojo Grade from Hold to Sell. Despite recent positive price momentum, the company’s elevated price-to-earnings and price-to-book ratios relative to historical and peer averages raise questions about its current price attractiveness for investors.

Read full news article

Piramal Pharma Ltd Quality Grade Downgrade Highlights Fundamental Challenges

2026-07-31 08:00:07

Piramal Pharma Ltd has recently experienced a downgrade in its quality grade from 'Average' to 'Below Average' as of 16 July 2026, reflecting a notable deterioration in key business fundamentals. This shift accompanies a downgrade in the Mojo Grade from Hold to Sell, signalling growing concerns over the company’s operational efficiency, profitability, and capital structure amid a challenging pharmaceutical sector landscape.

Read full news article

Are Piramal Pharma Ltd latest results good or bad?

2026-07-30 19:23:11

Piramal Pharma Ltd's latest financial results for Q1 FY27 present a mixed operational picture. The company reported consolidated net sales of ₹2,269.92 crores, reflecting a year-on-year growth of 17.39%. This increase was driven by improved demand in its Contract Development and Manufacturing Organisation (CDMO) and Consumer Healthcare segments. However, there was a significant sequential decline of 17.51% compared to the previous quarter, indicating volatility in pharmaceutical order flows. Despite the revenue growth, Piramal Pharma faced challenges with profitability, as evidenced by a consolidated net loss of ₹69.39 crores, which widened substantially compared to the previous quarter. The operating margin, while showing a year-on-year improvement to 8.60%, was considerably lower than the 16.74% margin achieved in the previous quarter. This highlights ongoing operational inefficiencies and high financial...

Read full news article

View All News